tiprankstipranks
AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
The Fly

AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage

Consensus $4.56. Backs FY24 revenue view up low double-digit to low teens percentage, consensus $50.95B. Sees FY24 core tax rate 18%-22%.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles